ArticleCancer research and treatment2023

PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients.

Ju Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.